Cargando…
Antiplatelet Therapy for Acute Respiratory Distress Syndrome
Acute respiratory distress syndrome (ARDS) is a common and devastating syndrome that contributes to serious morbidities and mortality in critically ill patients. No known pharmacologic therapy is beneficial in the treatment of ARDS, and the only effective management is through a protective lung stra...
Autores principales: | Chen, Chuan-Mu, Lu, Hsiao-Ching, Tung, Yu-Tang, Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399831/ https://www.ncbi.nlm.nih.gov/pubmed/32708068 http://dx.doi.org/10.3390/biomedicines8070230 |
Ejemplares similares
-
The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis
por: Wang, Yingqin, et al.
Publicado: (2018) -
Effect of Antiplatelet Therapy on Acute Respiratory Distress Syndrome and Mortality in Critically Ill Patients: A Meta-Analysis
por: Wang, Lijun, et al.
Publicado: (2016) -
Aspirin Attenuates Hyperoxia-Induced Acute Respiratory Distress Syndrome (ARDS) by Suppressing Pulmonary Inflammation via the NF-κB Signaling Pathway
por: Tung, Yu-Tang, et al.
Publicado: (2022) -
Acute respiratory distress syndrome
por: Chen, Hsing I., et al.
Publicado: (2003) -
Prognostic factors in the acute respiratory distress syndrome
por: Chen, Wei, et al.
Publicado: (2015)